Efficacy and Safety Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03444870 |
|
Recruitment Status :
Active, not recruiting
First Posted : February 23, 2018
Last Update Posted : February 9, 2023
|
Sponsor:
Hoffmann-La Roche
Information provided by (Responsible Party):
Hoffmann-La Roche
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Active, not recruiting |
|---|---|
| Actual Primary Completion Date : | September 26, 2022 |
| Estimated Study Completion Date : | February 20, 2023 |